Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 3.19% is 123% above its 5-year average of -13.97%, near the high end of its 5-year range (-69.29%–5.42%).
42.35% above its 12-month average of 2.24%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 5.42%.
NET PROFIT MARGIN
3.19%
NET PROFIT MARGIN AVG TTM
2.24%
NET PROFIT MARGIN AVG 3Y
-3.39%
NET PROFIT MARGIN AVG 5Y
-13.97%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+42.35%
CURRENT VS 3Y AVG
+194.08%
CURRENT VS 5Y AVG
+122.84%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 835 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
LifeStance Health Group, Inc.
Market Cap
$4.68B
Net Profit Margin
3.19%
TTM Avg
2.24%
3Y Avg
-3.39%
5Y Avg
-13.97%
Market Cap
$4.66B
Net Profit Margin
3.68%
TTM Avg
3.96%
3Y Avg
4.48%
5Y Avg
3.62%
Market Cap
$4.66B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.70B
Net Profit Margin
-1570.85%
TTM Avg
-4668.05%
3Y Avg
-2830.27%
5Y Avg
-2034.87%
Market Cap
$4.72B
Net Profit Margin
8.43%
TTM Avg
-12.40%
3Y Avg
-46.69%
5Y Avg
-46.69%
Market Cap
$4.79B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.81B
Net Profit Margin
-139.18%
TTM Avg
-15.29%
3Y Avg
-73.58%
5Y Avg
-122.19%
Market Cap
$4.42B
Net Profit Margin
-55.82%
TTM Avg
-71.50%
3Y Avg
-84.24%
5Y Avg
-84.24%
Market Cap
$4.40B
Net Profit Margin
26.65%
TTM Avg
8.56%
3Y Avg
0.11%
5Y Avg
0.58%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LifeStance Health Group, Inc. (LFST) | $4.68B | 3.19% | 2.24% | -3.39% | -13.97% |
| Option Care Health, Inc. (OPCH)vs › | $4.66B | 3.68% | 3.96% | 4.48% | 3.62% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.66B | 0.00% | 0.00% | 0.00% | 0.00% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.70B | -1570.85% | -4668.05% | -2830.27% | -2034.87% |
| BillionToOne, Inc. (BLLN)vs › | $4.72B | 8.43% | -12.40% | -46.69% | -46.69% |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.79B | 0.00% | 0.00% | 0.00% | 0.00% |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.81B | -139.18% | -15.29% | -73.58% | -122.19% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.42B | -55.82% | -71.50% | -84.24% | -84.24% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.40B | 26.65% | 8.56% | 0.11% | 0.58% |
| Erasca, Inc. (ERAS)vs › | $4.96B | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
5.0%
Net Profit Margin
3.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 5.42% |
| 2026-03-31 | 3.53% |
| 2025-12-31 | 3.05% |
| 2025-09-30 | 0.30% |
| 2025-06-30 | -1.10% |
| 2025-03-31 | 0.21% |
| 2024-12-31 | -2.19% |
| 2024-09-30 | -1.90% |
| 2024-06-30 | -7.45% |
| 2024-03-31 | -7.02% |
| 2023-12-31 | -16.02% |
| 2023-09-30 | -23.42% |
| 2023-06-30 | -17.52% |
| 2023-03-31 | -13.56% |
| 2022-12-31 | -20.34% |
| 2022-09-30 | -17.40% |
| 2022-06-30 | -32.80% |
| 2022-03-31 | -30.69% |
| 2021-12-31 | -56.86% |
| 2021-09-30 | -69.29% |
| 2021-06-30 | -43.62% |
| 2021-03-31 | -6.07% |
| 2020-12-31 | -4.65% |
| 2020-09-30 | -3.23% |
| 2020-06-30 | -9.55% |
| 2020-03-31 | 3.63% |
